Cancer Research at the Division of Pulmonology

Lung cancer is the leading cause of cancer death worldwide. Non-small lung cell cancer (NSCLC) is the most common form of lung cancer. Although new therapies have considerably improved survival, patients rarely survive for more than 5 years. There is a tremendous need for a better understanding of the molecular and genetic mechanisms of the disease.

The aim of the Lung Cell Laboratory is to investigate the molecular mechanisms controlling proliferation and apoptosis of NSCLC cells and to elucidate the role of their microenvironment. Our research is focussing on oxygen and substrate availability, and on metabolic and epigenetic changes.

I am proud that in our laboratory, dedicated scientists and a number of excellent technicians and students have pioneered this challenging research field.

Horst Olschewski, MD, Professor of Medicine, Director, Div. Pulmonology

Hrzenjak Group Members and projects​

Leithner Group Members and projects​


f. l. Katharina Leithner, Priv.-Doz. Dr. med. PhD, Andelko Hrzenjak, Assoc. Prof. PhD., Alexandra Bertsch, MSc.

m. l. Elisabeth Smolle, Dr. med., Irina Fadejeva, Dr. med., Carina Seidl, BSc.

b. l. Felix Prinz, BSc., Gabriele Grasmann, MSc., Katrin Panzitt, PhD.​

Copyright: @Andelko Hrzenjak
Letzte Aktualisierung: 15.10.2018